No takes yet. Share an insight, caveat, or question.
New platform accurately quantifies TBI biomarkers GFAP and UCH-L1, suggesting rapid point-of-care applications.
Minhao Liu (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: